MIST - Milestone Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

MIST is currently covered by 5 analysts with an average price target of $8.58. This is a potential upside of $6.95 (426.38%) from yesterday's end of day stock price of $1.63.

Milestone Pharmaceuticals's activity chart (see below) currently has 16 price targets and 23 ratings on display. The stock rating distribution of MIST is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.57% with an average time for these price targets to be met of 3.6 days.

Highest price target for MIST is $11, Lowest price target is $4, average price target is $8.58.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 26-Feb-2024. First documented stock forecast 03-Jun-2019.

Best performing analysts who are covering MIST - Milestone Pharmaceuticals:

Edward Tenthoff Leland Gershell Chris Howerton Ritu Baral Patrick Trucchio

Currently out of the existing stock ratings of MIST, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$7.37 (452.15%)

32

3 months 28 days ago

0/2 (0%)

$7.12 (378.72%)

Buy

11

$9.37 (574.85%)

13

8 months 13 days ago

0/6 (0%)

$7.83 (247.00%)

Hold

4

$2.37 (145.40%)

10 months 4 days ago

0/2 (0%)

$0.56 (16.28%)

Buy

10

$8.37 (513.50%)

10

1 years 11 months 22 days ago

3/7 (42.86%)

$3.85 (62.60%)

18

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MIST (Milestone Pharmaceuticals) average time for price targets to be met?

On average it took 3.6 days on average for the stock forecasts to be realized with a an average price target met ratio 8.57

Which analyst has the current highest performing score on MIST (Milestone Pharmaceuticals) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on MIST (Milestone Pharmaceuticals) with a proven track record?

PATRICK TRUCCHIO

Which analyst has the most public recommendations on MIST (Milestone Pharmaceuticals)?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 6 ratings on MIST

Which analyst is the currently most bullish on MIST (Milestone Pharmaceuticals)?

Leland Gershell with highest potential upside - $9.37

Which analyst is the currently most reserved on MIST (Milestone Pharmaceuticals)?

Patrick Trucchio with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?